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Abstract
Diet has been shown to have an effect on both inflammation and oesophageal cancer. This study investigated the association between the
dietary inflammatory index (DII®) and the risk of oesophageal cancer in Xinjiang Uyghur Autonomous Region, China. A case–control study
was conducted during 2008–2009 in Urumqi and Shihezi. DII scores were calculated based on dietary intake assessed by a validated FFQ
administered to 359 incident oesophageal cancer patients and 380 hospital-based controls. Higher DII scores indicate more pro-inflammatory
diets. Logistic regression analyses were performed to assess the association between DII scores and oesophageal cancer risk. Oesophageal
cancer patients had a significantly higher median DII score (−0·35; interquartile range (IQR)= −2·25, 1·86) than that of controls
(−1·41; IQR −3·07, 0·40). Multivariable logistic analysis revealed a positive association between higher DII scores and oesophageal cancer risk
(ORQuartile 4 v. 1 2·55; 95% CI 1·61, 4·06; Ptrend< 0·001). A pro-inflammatory diet appears to be associated with an increased risk of oesophageal
cancer in Xinjiang Uyghur Autonomous Region. Specific carcinogenic mechanisms are discussed. Accumulating evidence, to which the study
contributes, indicates that encouraging the intake of more anti-inflammatory foods may be a strategy to protect against oesophageal cancer in
this high-risk area of China.
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Oesophageal cancer has the eighth highest incidence of all
cancers worldwide, with 455 800 new cases and 400 200 deaths
estimated to have occurred in 2012(1). Incidence rates of
oesophageal cancer vary considerably across different
geographic regions(2), highlighting the potential role of nutri-
tional and lifestyle factors in oesophageal cancer aetiology.
Because of the lack of early clinical symptoms, oesophageal
cancer is typically diagnosed at an advanced stage. Prognoses
for these patients remain very poor, with a 5-year survival rate
of< 20%(3). Therefore, primary prevention of oesophageal
cancer is a major public health priority.
There are two histological types of oesophageal cancer –
squamous cell carcinoma and adenocarcinoma. Although
squamous cell cancers are thought to be more strongly asso-
ciated with tobacco exposure(4,5), both types have been found
to be associated with diet-related inflammation based on the
dietary inflammatory index (DII®)(6). On the basis of recent data
collected from the Chinese National Central Cancer Registry,
oesophageal squamous cell cancer (ESCC) was the most com-
mon type, being responsible for nearly 90% of the cases of
oesophageal carcinoma in China(7). It has been well established
that tobacco smoking and alcohol drinking are important risk
factors for ESCC(8). A diet high in processed meat and frequent
drinking of very hot beverages may also increase the risk of
developing ESCC. The major aetiological factors for oeso-
phageal adenocarcinoma (EAC) are gastro-oesophageal reflux
and body fatness (as indicated by increased BMI, waist
circumference and waist:hip ratio). There is some evidence that
low intake of fruits and vegetables is linked to an increased risk
of both ESCC and EAC(9).
Chronic inflammation is a state of continuous presence of
inflammatory cytokines in circulation and in the tissues, and has
Abbreviations: DII, dietary inflammatory index; EAC, oesophageal adenocarcinoma; ESCC, oesophageal squamous cell cancer.
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been shown to play a crucial role in the development of various
epithelial cancers(10,11). In particular, it has been shown that
chronic inflammation is an important risk factor in the
development of oesophageal cancer, especially epithelial
damage involved in ESCC(12,13).
Dietary habits represent modifiable factors that have been
shown to influence both inflammation(14–17) and oesophageal
cancer(18–20). Diet represents a complex set of exposures that
often interact, and has a cumulative effect on both inflammatory
responses and health outcomes. The DII was developed to
assess the inflammatory potential of an individual’s diet(21).
A pro-inflammatory diet is characterised by a high consumption
of foods rich in SFA and carbohydrates, and a low consumption
of foods rich in fibre, PUFA, flavonoids and other antioxidant
dietary components. The DII has been validated in a variety of
longitudinal and cross-sectional studies with various inflam-
matory markers, including C-reactive protein (CRP)(22), IL-6(23)
and TNF-α(24). The DII has been associated with the risk of
colorectal cancer in case–control studies in Spain and Italy(25,26),
in three cohort studies from the USA(27–29) and risk of various
cancers in case–control studies in Italy(30–33). Specifically
related to oesophageal cancer, the DII has been shown to be
associated with oesophageal cancer in Italy, Iran, Sweden and
Ireland(6,24,31,34).
Xinjiang Uyghur Autonomous Region, located in the north-
west of China, is one of the areas constituting the ‘Asian
oesophageal cancer belt’(35). The objective of the present study
was to investigate whether pro-inflammatory diets, as measured
by the DII, are associated with increased risk of oesophageal
cancer among adults residing in this remote region of China.
This is the first study to examine this association in China.
Methods
Study design and participants
A hospital-based case–control study of oesophageal cancer was
conducted in Urumqi and Shihezi, Xinjiang Uyghur Auto-
nomous Region of China, between January 2008 and December
2009. Participants were recruited from the Xinjiang Tumor
Hospital, Shihezi People’s Hospital, Kuitong Hospital and No. 1
Affiliated Hospital of Shihezi University. Medical records and
pathology reports were reviewed to identify patients with
histopathologically confirmed incident oesophageal cancer that
had been diagnosed within the previous 12 months. Patho-
logical diagnoses were based on the International Classification
of Disease for Oncology (ICD-O-3 codes: C150-C155, C158,
C159)(36). Patients without histopathologically confirmed
oesophageal cancer and those with reported memory problems
were excluded. Of the total 364 incident eligible patients
identified, 359 consented to participate.
During the same period, controls were recruited from
inpatient wards of the Departments of Ophthalmology,
Orthopaedics, Respiratory Diseases and Physiotherapy at
the same hospitals. Exclusion criteria for controls were previous
diagnosis of a malignant disease, on long-term medical diet
and self-reported memory problems. Random numbers were
generated using the software Research Randomizer
(http://www.socialpsychology.org) to make a final selection
whenever more controls were available than could be inter-
viewed. Of the 400 eligible controls who were frequency-
matched to cases on sex and age (±5 years), 380 eventually gave
their consent to participate in the study (with a response rate of
95%). No significant differences were found in demographic
variables (age, education and marital status) between partici-
pants and non-participants in both case and control groups.
Given the sample size of 359 case patients and 380 control
participants and a two-sided statistical significance level of
0·05, our study achieved more than 99% power to detect a
2-fold increased risk of oesophageal cancer associated with
pro-inflammatory diets(31). For this power calculation, the pre-
valence of consuming a pro-inflammatory diet was estimated at
40 and 25% in the cancer patients and control group,
respectively.
The study protocol was approved by the participating
hospitals and the Human Research Ethics Committee of Curtin
University (approved no. HR 56/2006). Written informed
consent was obtained from all participants, who were assured
of confidentiality of the information provided and their right to
withdraw at any time without prejudice.
Interview and exposure measurements
All participants were interviewed in-person by trained nurses,
usually in the presence of their next-of-kin, to facilitate the recall
of dietary habits(37). The nurses were aware of the case–control
status of the participants, but remained blind to the study
hypothesis. The structured questionnaire composed sections on
demographic characteristics, anthropometry, personal health and
family medical histories, diet and lifestyle, including cigarette
smoking and alcohol drinking. A 137-item semi-quantitative FFQ,
which had been validated and included fruits, vegetables, meat,
poultry, cereals and beverages commonly consumed in North-
western China, was used to collect dietary information(38).
Frequency and quantity of intake were recorded in detail. The
reference recall period for dietary variables was set at 5 years
before diagnosis for cases and 5 years before interview for
controls. Participants who consumed at least 500ml of alcoholic
beverages per week were classified as ‘often’; otherwise, they
were referred to as ‘never/seldom’ drinkers.
Daily intakes of carbohydrate, protein, cholesterol, fat, SFA,
fibre, niacin, folic acid, thiamin, riboflavin, vitamin C, vitamin E,
vitamin B6, β-carotene, Fe, Mg and Zn were estimated based on
the frequency and amounts of each food or beverage item
consumed using the Chinese Food Composition Tables(39). The
US Department of Agriculture nutrient database(40) was used for
the conversion to vitamin B12, MUFA, n-3, n-6, PUFA and SFA,
as such values were unavailable from the Chinese Food
Composition Tables.
Calculation of dietary inflammatory index scores
The development(17) and validation(22) of the DII has been
explained elsewhere. Through evaluation of peer-reviewed
literature published from 1950 to 2010, the score is based on
1943 articles linked to forty-five individual nutrient, food or
flavonoid intake parameters. Points were assigned to each of
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these parameters according to whether they increased (+1),
decreased (−1) or had no (0) effect on six established inflam-
matory biomarkers: IL-1b, IL-4, IL-6, IL-10, TNF-α and CRP.
The score for each of the food parameters was weighted
according to the study designs and total number of research
articles. Overall parameter-specific inflammatory effect scores
were then calculated based on the ratio of the total weighted
number of articles:the weighted pro- and anti-inflammatory
articles for each parameter followed by subtracting the anti-
inflammatory fraction from the pro-inflammatory fraction.
Parameters that had a robust pool of literature, that is greater
than the median number of 236 weighted articles, were
assigned the full value of that score. Parameters with a number
of weighted articles <236 were adjusted according to the
distance of their number from this median.
Actual dietary intake data from the FFQ were adjusted against
a reference global daily mean and standard deviation intake for
each parameter to obtain a z score. The global intake data were
based on consumption data from eleven countries in different
parts of the world. To reduce the effect of skewness, a common
occurrence in dietary data, z scores were converted to pro-
portions. These, in turn, were centred on zero by doubling the
proportion and subtracting 1. The centred proportion for each
intake parameter was multiplied by its respective parameter-
specific inflammatory effect score. All of the food-parameter-
specific DII scores were then summed to create the overall DII
score for each participant in the study, DII= b1×n1 + b2×n
2 +
… + b22×n22, where bi (i= 1,…, 23) refers to the literature-
derived inflammatory effect scores for each of the evaluable
food parameters and ni refers to the food-parameter-specific
centred percentiles, which were computed from the FFQ-
derived dietary data. The steps involved in DII calculation are
shown in Fig. 1. For the current study, data on twenty-three of
the forty-five DII food parameters could be derived from the
FFQ and were thus used for calculating the DII scores. These
include energy, carbohydrate, protein, fat, SFA, iron, chole-
sterol, fibre, PUFA, n-3, n-6, niacin, thiamin, riboflavin, Mg, Zn,
vitamin C, vitamin E, vitamin B6, B12, β-carotene, garlic and
onions. Alcohol intake was not included in the DII calculation
because daily consumption information was not recorded. All
of these food-parameter-specific DII scores are then summed to
create the overall DII score for each subject in the study.
Statistical analysis
The DII score was categorised into quartiles with cut-off points
based on the control distribution. The χ2 test was used for
categorical variables. Either the Student’s t test or the Mann–
Whitney U test was used for continuous variables to compare
the sample characteristics and DII scores between case and
control groups. χ2 and one-way ANOVA tests were next con-
ducted to test four differences in participant characteristics
across quartiles of the DII score by case and control status.
Unconditional logistic regression analyses were then per-
formed to ascertain the association between DII score and the
oesophageal cancer risk, with the lowest level of DII score
being the reference category. Potential confounding variables
considered were age (years), sex, education level (none/
primary, secondary, tertiary), BMI (5 years ago, kg/m2), total
energy intake (kJ/d (kcal/d)), smoking status (never, ever),
alcohol drinking (never/seldom, often) and family history of
cancer in first-degree relatives (no, yes). These variables were
either established or plausible risk factors based on findings in
the peer-reviewed literature. All of the variables were included
in the multivariable logistic regression model.
In addition to reporting crude and adjusted OR and cor-
responding 95% CI, dose–response relationships were assessed
by tests for linear trend. All statistical analyses were performed
using the SPSS® package version 22 (IBM Corp.).
Results
Table 1 compares characteristics and DII scores of the sample
by case–control status. The case and control participants were,
on average, 61·0 (SD 11·4) years old with a mean BMI of 24·1
(SD 3·7) kg/m2. Approximately, 72% of cases were male, 54%
smoked and 46% regularly drank alcoholic beverages.
Compared with the controls, patients with oesophageal cancer
tended to belong to an ethnic minority group (as compared
with the Han majority), have lower education level and have a
family history of oesophageal cancer. DII scores in this study
ranged from −4·72 (most anti-inflammatory score) to 4·18 (most
pro-inflammatory score). The median DII score among
oesophageal cancer patients (−0·35, interquartile range (IQR)
−2·25, 1·86) was significantly higher than that of their control
counterparts (−1·41, IQR −3·07, 0·40).
Study characteristics across quartiles of DII are provided
in Table 2. Participants who consumed more pro-inflammatory
diets (i.e. with higher DII scores) were older, more likely to
belong to a minority ethnic group (as opposed to Han)
and to smoke.
The results of logistic regression analyses are shown
in Table 3. A higher DII score (indicating a more pro-
inflammatory diet) was associated with an increased risk of
oesophageal cancer, with a significant dose–response relation-
ship (Ptrend< 0·001). The adjusted OR was 2·55 (95% CI 1·61,
4·06) for participants in the highest quartile of DII scores
compared with those in the lowest quartile. Belonging to an
ethnic minority group (adjusted OR 1·86; 95% CI 1·24, 2·80),
having a family history of oesophageal cancer (adjusted OR
2·74; 95% CI 1·60, 4·66), an education level lower than
secondary school (adjusted OR 1·82; 95% CI 1·09, 3·06) and
smoking (adjusted OR 1·59; 95% CI 1·07, 2·36) also were
significantly and independently associated with an elevated risk
of oesophageal cancer. None of their interactions with DII was
found to be significant.
Discussion
Findings from this case–control study in Northwestern China
suggest that consuming a more pro-inflammatory diet, as evi-
denced by higher DII scores, is associated with an increased risk
of oesophageal cancer. This is the first study in China to explore
the association between DII scores and oesophageal cancer. Our
findings are generally in line with the results obtained from a
population-based case–control study from Sweden, in which the
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significant associations with DII were observed for oesophageal
squamous cell carcinoma (ORQuartile 4 v. 1 4·35; 95% CI 2·24, 8·43),
EAC (ORQuartile 4 v. 1 3·59; 95% CI 1·87, 6·89) and gastro-
oesophageal junctional adenocarcinoma (ORQuartile 4 v. 1 2·04;
95% CI 1·24, 3·36). Significant trends across quartiles of DII were
observed for all oesophageal cancer subtypes(6). Results from the
current study also are consistent with those of two previous
studies undertaken in Iran(24) and Italy(31), both of which showed
that a pro-inflammatory diet is associated with a higher risk of
oesophageal squamous cell carcinoma. In addition to these
studies (ORdii> 1·20 v.≤1·20= 8·24; 95% CI 2·03, 33·47 and
ORquartile 5 v. 1 2·46; 95% CI 1·40, 4·36; Ptrend<0·001, respectively),
the DII also has been shown to be associated with increased
odds of reflux oesophagitis (OR 1·87; 95% CI 0·93, 3·73), sig-
nificantly increased odds of Barrett’s oesophagus (OR 2·05; 95%
CI 1·22, 3·47) and EAC (OR 2·29; 95% CI 1·32, 3·96)(34).
One of the possible mechanisms behind the observed positive
association between the DII and oesophageal cancer may be
mediated by increasing levels of pro-inflammatory cytokines
such as vascular endothelial growth factor, CRP and IL-8. These
cytokines form an important component of the oesophageal
tumour micro-environment. As such, they play a key role
in cancer development, growth and progression(41) through
various processes including promoting proliferation, inducing
Review of articles published from 1950 to 2010 resulting in 1943 studies linking a total of
45 food parameters with inflammatory biomarkers
A score for each food parameter was calculated giving:
+1 to each article if the effects were pro-inflammatory (significantly increased IL-1, IL-6,
TNF- or CRP, or decreased IL-4 or IL-10),
–1 if the effects were anti-inflammatory (significantly decreased IL-1, IL-6, TNF- or CRP,
or increased IL-4 or IL-10),
0 if the food parameter did not produce any significant change in inflammation
The score for each food parameter was weighted according to the study design. The
weights were 10 (experimental design), 8 (observational), 7 (case–control), 6 (cross-
sectional), 5 (experimental with animals), 3 (cell culture)
A food parameter-specific overall inflammatory effect score was calculated by substracting
the anti-inflammatory fraction from the pro-inflammatory fraction. This score was
corrected if the total weighted number of articles was <236. In these cases the raw overall
inflammatory score is multiplied by the total weighted number of articles divided by 236
22 food parameters were not
available in this study
z-score and centred-percentiles for each of the 23 food parameters for each participant of
this study were calculated based on the average and standard deviation for each food
parameter obtained from the global database which was created from the consumption
of the original 45 food parameters fron 11 countries from around the world
The centred percentile for each food parameter was multiplied by the the respective
‘overall food parameter-specific inflammatory effect score’ to obtain the ‘food parameter-
specific Dll score’
All of the ‘food parameter-specific Dll scores’ are summed to create the ‘overall Dll score’
for each individual
Fig. 1. Sequence of steps in creating the dietary inflammatory index (DII) in the Chinese oesophageal cancer case–control study. CRP, C-reactive protein.
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angiogenesis and by inhibiting the recruitment of immune cells to
the tumour site(42). Hypoxia, a common state of low O2 levels in
inflamed tissues, causes DNA damage and induces tumorigenic
factors that further result in progression of cancer(42). Inflamma-
tion also alters the extracellular matrix and provides structural
support to developing tumours(42). Resveratrol, which is an
important component of grapes, has been found to be a natural
cyclo-oxygenase-2 (COX-2) inhibitor that is involved in the anti-
inflammatory pathway(43). Another phytochemical, curcumin,
which is present in large quantities in turmeric, can down-regulate
inflammation, and has been demonstrated to be capable of
preventing activation of a pro-inflammatory chemical – NF-κB(44).
n-3 Fatty acids, which are abundant in marine fish that are fairly
rarely eaten in this population, can stimulate anti-inflammatory
signalling molecules that have been associated with oesophageal
cancer protection(45).
This study adds to the body of research that clearly indicates
a role of diet-associated inflammation in oesophageal carcino-
genesis. Unlike the effect of tobacco, which appears to be
stronger for squamous cell cancers(4,5), the effect of diet appears
to affect both histopathologic subtypes(34,46–48). This finding is
reinforced by findings from our study in Sweden(6), which
found nearly identical increased odds of 4·35 and 3·59,
respectively, for ESCC and EAC.
Some mechanisms may manifest irrespective of specific
histopathological type. For example, both CRP and certain
interleukins such as IL-6 appear to affect both ESCC and
EAC(49). These cytokines regulate processes associated with
inflammation that occur along carcinogenic pathways that
appear to be operative irrespective of histopathological
subtype. Both histopathologic subtypes are well known to be
associated with inflammation. The effect of chronic inflamma-
tion in the growth of ESCC is well-established(31,50–52). Similarly,
the influence of inflammation in the process of malignant
transformation in the sequence from Barrett’s oesophagus to
frank adenocarcinoma is particularly well defined(53–55),
including the effect of oxidative stress, which is intimately
associated with both diet and inflammatory response, in relation
to reflux oesophagitis(56).
Some exposures, such as consuming beverages at very high
temperatures, will logically affect the proximal oesophagus,
where most ESCC occur(57). In addition, within China some
putative environmental causes have been suggested to affect
ESCC in particular(58).
Certain processes are emerging for specific cancer subtypes.
However, the specificity of the effect is hard to determine given
the infancy of the field. For example, the Janus kinase/signal
transducer and activator of transcription 3 (JAK/STAT3) may
play a unique role in ESCC by encouraging cross talk between
NF-κB and COX-2, which are well known to link inflammation
to tumorigenesis. Blocking the JAK/STAT3 pathway in ESCC
cell lines appears to regulate cell growth and inhibit angio-
genesis(59). With the rapid rise of EAC, there also has been an
interest in sorting out inflammation-related pathways for this
cancer. These include local immune response, tissue micro-
environment, metabolic profile, intracellular signalling and
microRNA(12). Given the current state of knowledge, there is
nothing compelling the view that these mechanisms are
exclusive to a particular histopathological type of tumour. For
example, although dysregulation of cytokines in ESCC is known
and members of VEGF family may play an important role in
ESCC(60), this same process may apply to EAC. Similarly, while
the effect of the diet on the microbiome has been investigated
in EAC(61), these effects may not be specific to histology of the
cancer. However, it must be borne in mind that adenocarci-
nomas occur in the distal oesophagus where the influence of
microbiome could be different from that in the proximal
oesophagus. This potential lack of specificity may help to put in
perspective the results of this Chinese study in which it is not
been possible to distinguish subtype (although there are many
more squamous cell cancers than adenocarcinomas in this
population).
Limitations of this study include the retrospective nature of
the case–control design. Although exposure information was
collected with an instruction to report on exposures in the past,
true temporal sequence cannot be established with certainty.
This limits inferences regarding the causal relationship between
Table 1. Comparison of participant characteristics and dietary inflam-
matory index between case and control groups, Xinjiang, China, January
2008–December 2009
(Numbers and percentages; mean values and standard deviations;
medians and interquartile ranges (IQR))
Cases Controls
Variables n % n % P *
Sex 0·62
Male 260 72·4 269 70·8
Female 99 27·6 111 29·2
Ethnic group 0·001
Han 270 75·2 322 84·7
Minority 89 24·8 58 15·3
Education level <0·001
None/primary 183 51·0 136 35·8
Secondary 140 39·0 191 50·3
Tertiary 36 10·0 53 13·9
Smoking status 0·19
Never 164 45·7 192 50·5
Ever 195 54·3 188 49·5
Alcohol drinking 0·22
Never/seldom 193 53·8 187 49·2
Often 166 46·2 193 50·8
Family history of cancer
in first-degree relatives
<0·001
No 306 85·2 356 93·7
Yes 53 14·8 24 6·3
Age at interview (years) 0·34
Mean 61·4 60·6
SD 11·0 11·8
BMI (5 years ago, kg/m2) 0·18
Mean 24·3 24·0
SD 3·8 3·6
Energy intake (kJ/d) 0·047
Mean 18 031·8 19 700·6
SD 11 216·0 11 361·7
Energy intake (kcal/d) 0·047
Mean 4309·7 4708·5
SD 2680·7 2715·5
Dietary inflammatory index <0·001
Median −0·35 −1·41
IQR −2·25, 1·86 −3·07, 0·40
* χ2, Student’s t test or Mann–Whitney U test for difference between cases and
controls.
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pro-inflammatory diet and oesophageal cancer risk. We also
cannot rule out selection bias (i.e. towards healthier cases), as
patients who died from oesophageal cancer in the last
12 months were not included in the study. Nevertheless, the use
of four hospitals reduced selection bias to some extent, as these
hospitals serve the entire catchment region. Therefore, the
participants are probably representative of the target population
of Xinjiang Uyghur Autonomous Region. Although the recall of
habitual food and beverage consumption should not be affec-
ted by case–control status, dietary assessment was made on the
basis of self-report, which probably introduced some recall
error in the response of participants, especially because the
recall period of dietary intake was set at 5 years before the
interview. Face-to-face interviews were thus conducted in
the presence of next-of-kin to help improve the accuracy of
their answers(37). Furthermore, information bias was minimised
by binding all participants to the study hypothesis; i.e. the idea
that pro-inflammatory diets are associated with increased risk of
oesophageal cancer in the north-west of China was not com-
monly held at the time of interview. Alcoholic beverage intake
also represents an area of weakness as status was categorised as
never/seldom v. often, instead of daily intake of alcohol.
Because this variable was used in the multivariable logistic
regression model, some residual confounding may remain.
Finally, information on the histologic subtypes of oesophageal
cancer was not available to enable subgroup analyses of
oesophageal tumours. However, the vast majority of cancers in
this study are, no doubt, ESCC.
Table 2. Participant characteristics across quartiles (Q) of dietary inflammatory index (DII) among all participants, Xinjiang, China, January
2008–December 2009
(Numbers and percentages; mean values and standard deviations)
Q1 (<−3·067)
(n 149)
Q2 (−3·067 to −1·462)
(n 169)




Characteristics n % n % n % n % P *
Sex 0·36
Male 112 75·2 123 72·8 132 72·9 162 67·5
Female 37 24·8 46 27·2 49 27·1 78 32·5
Ethnic group 0·002
Han 135 90·6 133 78·7 134 74·0 190 79·2
Minority 14 9·4 36 21·3 47 26·0 50 20·8
Education level 0·11
None/primary 57 38·3 69 40·8 71 39·2 122 50·8
Secondary 75 50·3 75 44·4 89 49·2 92 38·3
Tertiary 17 11·4 25 14·8 21 11·6 26 10·8
Smoking status 0·08
Never 58 38·9 82 48·5 92 50·8 124 51·7
Ever 91 61·1 87 51·5 89 49·2 116 48·3
Alcohol drinking 0·19
Never/seldom 74 49·7 78 46·2 92 50·8 136 56·7
Often 75 50·3 91 53·8 89 49·2 104 43·3
Family history of cancer in first-degree relatives 0·11
No 127 85·2 150 88·8 144 79·6 205 85·4
Yes 22 14·8 19 11·2 37 20·4 35 14·6
Age at interview (years) 0·25
Mean 61·3 59·8 62·2 60·8
SD 11·8 11·2 11·2 11·5
BMI (kg/m2) 0·69
Mean 22·3 22·3 21·9 22·3
SD 3·8 3·6 3·9 3·6
* χ2 Test or one-way ANOVA for difference among quartiles of DII.
Table 3. Oesophageal cancer risk for dietary inflammatory index in Xinjiang, China, January 2008–December 2009
(Numbers and percentages; odds ratios and 95% confidence intervals)
Cases Controls Crude Adjusted
Dietary inflammatory index n % n % OR 95% CI OR* 95% CI Pfor trend*
All participants (n 739) <0·001
Q1 (<−3·067) 54 15·0 95 25·0 1·00 1·00
Q2 (−3·067 to −1·462) 74 20·6 95 25·0 1·37 0·87, 2·15 1·39 0·86, 2·23
Q3 (−1·461 to 0·334) 86 24·0 95 25·0 1·59 1·02, 2·48 1·45 0·90, 2·34
Q4 (≥0·335) 145 40·4 95 25·0 2·69 1·76, 4·10 2·55 1·61, 4·06
Q, quartile.
* From logistic regression model adjusting for age (years), sex, ethnic group (Han, minority), education level (none/primary, secondary, tertiary), BMI (5 years ago, kg/m2), total
energy intake (kJ/d (kcal/d)), smoking status (never, ever), alcohol drinking (never/seldom, often) and family history of cancer in first-degree relatives (no, yes).
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Consumption of pro-inflammatory diets appears to be asso-
ciated with an increased risk of oesophageal cancer in North-
western China. Although further prospective cohort studies are
required to confirm the findings, discouraging the intake of
more pro-inflammatory foods, such as processed meat and red
meat, may be a strategy to protect against oesophageal cancer
in this high-risk area of China.
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